Introduction: Human aging is characterized by increasing vulnerability not only to diseases, but also to the treatments applied to that diseases. Geriatric depression is a frequent mental disorder often requiring pharmacological treatment, which commonly is added to other medications taken to treat chronic or acute co-morbidities. The challenges of appropriate treatment of elderly are increasingly recognized as an urgent health problem. Areas covered: The challenges of appropriate geriatric anti-depressant prescription, and the role of novel tools developed by Precision Medicine. The data were obtained searching in MEDLINE: pharmacokinetics, pharmacodynamics, pharmacogenetics, antidepressants, drug-drug interactions and elderly, in the period 1994–2016. Expert commentary: The Precision Medicine approach take advantage by novel decision-supporting tools, as pharmacogenomic testing, drug-drug interactions evaluation and therapeutic drug monitoring, allowing to improve informed-decision making in prescription of antidepressants.
Precise medical decision making in geriatric anti-depressant therapy / Gentile, Giovanna; Cipolla, Fabiola; Capi, Matilde; Simmaco, Maurizio; Lionetto, Luana; Borro, Marina. - In: EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT. - ISSN 2380-8993. - ELETTRONICO. - 1:4(2016), pp. 387-396. [10.1080/23808993.2016.1199951]
Precise medical decision making in geriatric anti-depressant therapy
GENTILE, GiovannaPrimo
;CIPOLLA, FABIOLASecondo
;CAPI, MATILDE;SIMMACO, Maurizio;BORRO, MarinaUltimo
2016
Abstract
Introduction: Human aging is characterized by increasing vulnerability not only to diseases, but also to the treatments applied to that diseases. Geriatric depression is a frequent mental disorder often requiring pharmacological treatment, which commonly is added to other medications taken to treat chronic or acute co-morbidities. The challenges of appropriate treatment of elderly are increasingly recognized as an urgent health problem. Areas covered: The challenges of appropriate geriatric anti-depressant prescription, and the role of novel tools developed by Precision Medicine. The data were obtained searching in MEDLINE: pharmacokinetics, pharmacodynamics, pharmacogenetics, antidepressants, drug-drug interactions and elderly, in the period 1994–2016. Expert commentary: The Precision Medicine approach take advantage by novel decision-supporting tools, as pharmacogenomic testing, drug-drug interactions evaluation and therapeutic drug monitoring, allowing to improve informed-decision making in prescription of antidepressants.File | Dimensione | Formato | |
---|---|---|---|
Gentile_ Precise-medical_2016.pdf
solo gestori archivio
Note: https://www.tandfonline.com/doi/full/10.1080/23808993.2016.1199951
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
985.35 kB
Formato
Adobe PDF
|
985.35 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.